Thèmes : diabetes care, glucose, hypoglycemie, centre information

	Accueil > Sitemap > Centre d'information > Références Medicales : Hypoglycémie > Holleman F., Schmitt H., Rottiers R., Rees A., Symanowski S., Anderson J.H. : Reduced frequency of severe hypoglycaemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group. Holleman F., Schmitt H., Rottiers R., Rees A., Symanowski S., Anderson J.H. : Reduced frequency of severe hypoglycaemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group.   Back Department of Internal Medicine, Diakonessenhuis, Utrecht, The Netherlands. Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group. OBJECTIVE: Several studies have suggested that use of the short-acting insulin analog, insulin lispro, in multiple injection therapy may reduce the risk of hypoglycemia in comparison with regular insulin. This effect might be more pronounced in well-controlled patients, since intensive treatment of IDDM increases the rate of severe hypoglycemic events. This study evaluated the effects of insulin lispro on glycemic control and hypoglycemia rates in well-controlled IDDM patients. RESEARCH DESIGN AND METHODS: This was an open, randomized, 6-month crossover study of 199 IDDM patients. Glycemic control was evaluated by HbA1c, home blood glucose measurements, and rate and timing of hypoglycemic events. At the end of the study, patients completed an evaluation form regarding therapy-related quality of life. RESULTS: HbA1c remained constant at approximately 7.3% throughout the study. Meal-related glucose excursions were significantly lower with insulin lispro compared with regular insulin (mean -0.8 +/- 1.7 vs. 1.1 +/- 1.6 mmol/l, P < 0.001), as was the within-day variability (M value 27.7 +/- 19.7 vs. 30.2 +/- 23.1, P = 0.007). The incidence of severe hypoglycemic events (58 vs. 36, P = 0.037) including coma (16 vs. 3, P = 0.004) was significantly lower with insulin lispro than with regular insulin. Patients felt that insulin lispro increased flexibility and freedom of lifestyle. CONCLUSIONS: In well-controlled IDDM patients, insulin lispro is associated with a lower risk of severe hypoglycemia and coma. If you would like to obtain the full article, please contact the Diabetes Care publication at the following e-mail address: customerservice@diabetes.org
Trucs & astuces pour les ados diabétiques, L'école Moi aussi je suis diabétique (jusqu'à 12 ans), Qu'est-ce qu'une hypo? Hypoglycémie, George E., Marques J.L., Harris N.D., Macdonald I.A., Hardisty C.A., Heller S.R. : Preservation of physiological responses to hypoglycaemia 2 days after antecedent hypoglycaemia in patients with IDDM. Dents en péril, Recommandations Le prélèvement capillaire, Vaag A., Pedersen K.D., Lauritzen M. Hildebrandt P., Beck Nielsen H. : Intramuscular versus subcutaneous injection of unmodified Insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus. Données personelles Références Medicales, Hypoglycémie Centre d'information, Download centre
BD et le logo BD sont des marques déposées de Becton Dickinson and Company. © 2005 BD